Treatment with Delipid Extracorporeal Lipoprotein Filter from Plasma after Intravenous Thrombolysis for Acute Ischemic Stroke: A Single-Center Experience

INTRODUCTION: The delipid extracorporeal lipoprotein filter from plasma (DELP) has been approved for the treatment of acute ischemic stroke (AIS) by the China Food and Drug Administration, but its effectiveness and mechanism are not yet fully determined. The purpose of this study was to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Yu, Zhou, Zhong-He, Hou, Xiao-Wen, Chen, Hui-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670379/
https://www.ncbi.nlm.nih.gov/pubmed/33091902
http://dx.doi.org/10.1159/000511050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670379/
https://www.ncbi.nlm.nih.gov/pubmed/33091902
http://dx.doi.org/10.1159/000511050

Ejemplares similares